Coca-Cola Europacific Partners vs Ambev
Major Coca-Cola bottler across Europe and Asia-Pacific vs Leading Latin American brewer with extensive distribution network. Which is the better buy for your portfolio in September 2026? Plain-English answer below.
Coca-Cola Europacific Partners bottles and distributes Coca-Cola products across Europe and the Pacific while Ambev does the same for Coca-Cola and owns dominant beer brands across Latin America. Both companies are anchor bottlers with exclusive franchise territories that insulate them from direct competition, yet their geographic exposures drive very different currency and macroeconomic risk profiles. The Coca-Cola Europacific Partners vs Ambev comparison unpacks volume trends, pricing strategies, and which franchise territory offers the stronger growth outlook.
Coca-Cola Europacific Partners bottles and distributes Coca-Cola products across Europe and the Pacific while Ambev does the same for Coca-Cola and owns dominant beer brands across Latin America. Both...
Why It’s Moving
CCEP slips as analysts flag limited upside despite steady buyback support
- JPMorgan reiterated an underweight view on CCEP, reinforcing the market’s concern that the stock’s valuation leaves limited room for disappointment.
- Investors are also watching CCEP’s ongoing EUR 1 billion buyback, which supports earnings per share but can’t fully offset worries about near-term upside.
- The latest trading updates show management continuing to repurchase and cancel shares, a sign of confidence in cash generation even as analysts remain cautious.
Ambev is moving on mixed earnings, cautious analyst sentiment, and uneven investor positioning
- Ambev’s latest quarterly results showed earnings in line with expectations but revenue came in below forecasts, pointing to softer-than-expected demand or pricing power.
- Recent reporting also highlights mixed investor positioning, with some funds adding to ABEV while others sharply reduced exposure, underscoring uncertainty around the stock’s near-term direction.
- The company’s small dividend declaration keeps income support in view, but the broader tone remains cautious as analysts continue to lean conservative on the name.
CCEP slips as analysts flag limited upside despite steady buyback support
- JPMorgan reiterated an underweight view on CCEP, reinforcing the market’s concern that the stock’s valuation leaves limited room for disappointment.
- Investors are also watching CCEP’s ongoing EUR 1 billion buyback, which supports earnings per share but can’t fully offset worries about near-term upside.
- The latest trading updates show management continuing to repurchase and cancel shares, a sign of confidence in cash generation even as analysts remain cautious.
Ambev is moving on mixed earnings, cautious analyst sentiment, and uneven investor positioning
- Ambev’s latest quarterly results showed earnings in line with expectations but revenue came in below forecasts, pointing to softer-than-expected demand or pricing power.
- Recent reporting also highlights mixed investor positioning, with some funds adding to ABEV while others sharply reduced exposure, underscoring uncertainty around the stock’s near-term direction.
- The company’s small dividend declaration keeps income support in view, but the broader tone remains cautious as analysts continue to lean conservative on the name.
Investment Analysis
Pros
- Reported strong FY 2024 financial results with 11.7% revenue growth and 19.4% operating profit increase, reflecting robust top and bottom-line performance.
- Geographically diversified operations including Europe, Australia, and Asia-Pacific, supporting stable revenue streams and market share gains.
- Announced a €1 billion share buyback program and maintains a solid dividend yield, indicating strong free cash flow and capital return focus.
Considerations
- Faces volume growth pressures with only 0.4% volume increase reported in Q3 2025, indicating potential challenges in expanding core product demand.
- Exposure to adverse external factors such as the soft consumer environment in Europe and regional disruptions, including typhoon flooding in the Philippines.
- High debt-to-equity ratio at approximately 144.8%, which could limit financial flexibility and increase leverage risk.
Ambev
ABEV
Pros
- Strong market position as a leading beverage company in Latin America with extensive distribution networks and popular brands.
- Recent focus on premiumisation and innovation in product portfolio, supporting potential revenue growth and improved profitability.
- Good operational cash flow generation which supports dividend payouts and investments in growth initiatives.
Considerations
- Geographic concentration in Latin America exposes the company to macroeconomic volatility and currency risks in emerging markets.
- Highly competitive market environment with pressure from global and regional beverage companies impacting market share and margins.
- Vulnerability to commodity price fluctuations, particularly sugar and aluminium, which can affect cost structures and margins.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next earnings date is typically expected around November 4–6, 2026, based on its historical reporting pattern. The upcoming report should cover Q3 2026. If the company confirms a specific release date, it is usually announced closer to the earnings window.
Ambev (ABEV) Next Earnings Date
Ambev S.A. is expected to report its next earnings on October 29, 2026. The release is for 3Q26, covering the third quarter of 2026. This date is the current market estimate and may change if the company announces an official schedule.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next earnings date is typically expected around November 4–6, 2026, based on its historical reporting pattern. The upcoming report should cover Q3 2026. If the company confirms a specific release date, it is usually announced closer to the earnings window.
Ambev (ABEV) Next Earnings Date
Ambev S.A. is expected to report its next earnings on October 29, 2026. The release is for 3Q26, covering the third quarter of 2026. This date is the current market estimate and may change if the company announces an official schedule.
Buy CCEP or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
